Panel looks to apply COVID-19 lessons to flu preparedness
The National Academy of Medicine has named an international committee to assess how COVID-19 vaccine development and other policies could facilitate global efforts to prepare for seasonal flu and a flu pandemic.
As part of the initiative, the Department of Health and Human Services has asked the National Academies of Sciences, Engineering, and Medicine to release consensus reports this fall on vaccine research and development; vaccine distribution and supply chains; public health interventions and countermeasures; and global coordination, partnerships and financing.
NAM will host a public workshop this spring to hear from experts and gather feedback to inform the reports.
Related News Articles
Headline
The Administration for Strategic Preparedness and Response June 25 announced a flu pandemic preparedness and response strategy in response to the threat of…
Headline
The Food and Drug Administration last week granted enforcement discretion for the use of conjunctival swabs by laboratories as part of human testing for H5N1…
Headline
The Centers for Disease Control and Prevention May 21 announced recommendations that flu surveillance systems continue operating at enhanced levels during the…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…